tirzepatide monograph FDA Grants a New Indication for Obesity Management Drug of the Day: Tirzepatide

Providers should explain this clearly and offer safety advice

Stress response and cortisol modulation Elevated cortisol is a common driver of insomnia and sleep fragmentation

Our comprehensive prior authorization support includes everything from initial submissions to consistent follow-through for approval

GLP-1 receptor agonists are the weight loss injections most commonly associated with dizziness

Terai and colleagues examined if non-enzymatic reduction of ascorbate by glutathione could function as a backup for DHAR activity

Side effects of melanotan II Short term side effects after administration include: Facial flushing Reduced appetite, nausea and vomiting In males, spontaneous erections 1-5 hours after administration (priapism), associated with yawning and stretching complex Long term, there is concern that melanotan II may increase the risk of: Melanoma a potentially serious form of skin cancer Deepening of the color of moles, new moles and atypical melanocytic naevi Melanonychia brown to black discoloration of one or more nails Suggested usage: daily for 1 - 2 weeks then one to two times weekly for maintenance